Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 8/20 | 0.61 |
| ▸ | TRIM24 | O15164 | 2/20 | 0.60 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.60 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | TLR2 | O60603 | 1/20 | 0.42 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.42 |
| ▸ | TLR6 | Q9Y2C9 | 1/20 | 0.42 |
| ▸ | CDK4 | P11802 | 1/20 | 0.42 |
| ▸ | CCND1 | P24385 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31539049 | 1.00 | ERN1 (0.61) | ERN1TRIM24TRIM33CA1CA2 | |
| SCHEMBL1232196 | 0.83 | LMNA (0.58) | ERN1TRIM24TRIM33CA1CA2 | |
| SCHEMBL4617412 | 0.79 | ERN1 (0.54) | ERN1TRIM24TRIM33MEN1KMT2A | |
| SCHEMBL16954374 | 0.79 | ERN1 (0.41) | ERN1TRIM24TRIM33CA1CA2 | |
| SCHEMBL503137 | 0.78 | CA1 (0.69) | ERN1TRIM24TRIM33CA1CA2 | |
| SCHEMBL3703256 | 0.77 | ERN1 (0.40) | ERN1TRIM24TRIM33CA1CA2 | |
| SCHEMBL40633 | 0.76 | LMNA (0.50) | ERN1TRIM24TRIM33CA1CA2 | |
| SCHEMBL6048616 | 0.76 | ERN1 (0.67) | ERN1TRIM24TRIM33CA1CA2 | |
| SCHEMBL29407137 | 0.76 | ERN1 (1.00) | ERN1TRIM24TRIM33CA1CA2 | |
| SCHEMBL36440 | 0.76 | ERN1 (1.00) | ERN1TRIM24TRIM33CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 539 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119528956-B | BODIPY light-cage chemiluminescent molecule, nano microsphere, and synthesis method and application thereof | 中南林业科技大学 | 2025-05-13 | — | — | CN | claimed |
| CN-119528956-A | BODIPY light-cage chemiluminescent molecule, nano microsphere, and synthesis method and application thereof | 中南林业科技大学 | 2025-02-28 | — | — | CN | claimed |
| CN-118324616-A | Synthesis method of 2-bromo-3- (phenylpropyl-2-alkyne-1-yloxy) benzaldehyde and derivatives thereof | 哈尔滨工业大学(深圳)(哈尔滨工业大学深圳科技创新研究院) | 2024-07-12 | — | — | CN | claimed |
| CN-115572218-B | Preparation method of 2-bromo-3-hydroxybenzaldehyde and related chemiluminescent substrate intermediate thereof | 江阴勒森生物科技有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-115572218-A | Preparation method of 2-bromo-3-hydroxybenzaldehyde and related chemiluminescent substrate intermediate thereof | 江阴勒森生物科技有限公司 | 2023-01-06 | — | — | CN | claimed |
| CN-109053443-A | The bromo- 3- aldehyde radical-phenoxy group of 4-(4-)-benzonitrile synthetic method | 杭州华东医药集团浙江华义制药有限公司 | 2018-12-21 | — | — | CN | claimed |
| CN-118271158-B | Method for synthesizing deuterium-labeled substance containing deuterium atom structural unit | 山东大学 | 2026-05-12 | — | — | CN | disclosed |
| CN-116829557-B | Pentaheterocycle compound, preparation method and application thereof | 上海艾力斯医药科技股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-12576158-B2 | Antibody drug conjugates with cleavable linkers | HEIDELBERG PHARMA RESEARCH GMBH (DE) | 2026-03-17 | — | — | US | disclosed |
| US-20250353874-A1 | GLUCOCORTICOID RECEPTOR AGONISTS | LILLY CO ELI (US) | 2025-11-20 | — | — | US | disclosed |
| US-12441726-B2 | Compounds and uses thereof | FOGHORN THERAPEUTICS, INC. (US) | 2025-10-14 | — | — | US | disclosed |
| US-12410187-B2 | Fused tricyclic compounds useful as anticancer agents | ASTRAZENECA AB (SE) | 2025-09-09 | — | — | US | disclosed |
| US-12404298-B2 | Glucocorticoid receptor agonists | ELI LILLY AND COMPANY (US) | 2025-09-02 | — | — | US | disclosed |
| US-20060047151-A1 | Optimized liquid-phase oxidation | ALPEK POLYESTER, S.A. DE C.V. (MX) | 2006-03-02 | — | — | US | disclosed |
| US-20060047155-A1 | Optimized liquid-phase oxidation | ALPEK POLYESTER, S.A. DE C.V. (MX) | 2006-03-02 | — | — | US | disclosed |
| US-20060047149-A1 | Optimized liquid-phase oxidation | GRUPO PETROTEMEX, S.A. DE C.V. (MX) | 2006-03-02 | — | — | US | disclosed |
| US-20060047157-A1 | Optimized liquid-phase oxidation | ALPEK POLYESTER, S.A. DE C.V. (MX) | 2006-03-02 | — | — | US | disclosed |
| US-5750631-A | CURABLE EPOXIDIZED PHENOLIC RESIN CONTAINING CHLORINE AND/OR BROMINE; FIREPROOFING, BY-PRODUCT INHIBITION | SHELL OIL COMPANY (US) | 1998-05-12 | — | — | US | disclosed |
| US-5077375-A | Molding materials | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-12-31 | — | — | US | disclosed |
| US-5008350-A | For encapsulating and laminating electonic components | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12410187-B2 | Fused tricyclic compounds useful as anticancer agents | MCL1, TP53, CCNA2 | ERN1 2189/4885TRIM24 3744/4885TRIM33 4054/4885 |
| US-12404298-B2 | Glucocorticoid receptor agonists | NR3C1, NR3C2, MC2R | ERN1 1650/4885TRIM24 2673/4885TRIM33 1304/4885 |
| US-20250353874-A1 | GLUCOCORTICOID RECEPTOR AGONISTS | NR3C1, NR3C2, MC2R | ERN1 1650/4885TRIM24 2673/4885TRIM33 1304/4885 |
| US-12441726-B2 | Compounds and uses thereof | VHL, CLN6, TFEB | ERN1 1926/4885TRIM24 2862/4885TRIM33 2868/4885 |
| US-12576158-B2 | Antibody drug conjugates with cleavable linkers | PTMS, C3AR1, ANPEP | ERN1 3176/4885TRIM24 2670/4885TRIM33 2547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.